• No results found

18 results with keyword: 'primary renal cell carcinoma metastases renal carcinoma cancer'

Somatic mutations in renal cell carcinomas from Chinese patients revealed by targeted gene panel sequencing and their associations with prognosis and PD-L1 expression

RCC : renal cell carcinoma; ccRCC : clear cell renal cell carcinoma; PRCC : papil- lary renal cell carcinoma; ChRCC : chromophobe renal cell carcinoma; TCGA : The Cancer Genome

Protected

N/A

6
0
0
2020
Are primary renal cell carcinoma and metastases of renal cell carcinoma the same cancer?

[24] detected that metastases demonstrated higher expression of programmed death ligand 1 (PD-L1) that connects with the costimulatory receptor on T cells and promotes inactivation

Protected

N/A

6
0
0
2021
Metastatic disease to the pancreas: an imaging challenge

The most common primary tumours to give rise to pancreatic metastases are lung cancer, breast cancer, renal cell carcinoma, malignant melanoma, carcinoma of gastrointestinal origin

Protected

N/A

8
0
0
2020
Identification of clear cell renal cell carcinoma and oncocytoma using a three gene promoter methylation panel

RCT: renal cell tumour; RCC: renal cell carcinoma; ccRCC: clear cell renal cell carcinoma; pRCC: papillary renal cell carcinoma; chRCC: chromophobe renal cell carcinoma; RO:

Protected

N/A

9
0
0
2020
SMG Bariatric Nutrition 102

McCaskill, MD East Lansing, MI 48823 thistinyscar.com Amanda Cooper, PA-C.. Andrea

Protected

N/A

30
0
0
2021
Identification of biomarkers of chromophobe renal cell carcinoma by weighted gene co-expression network analysis

ChRCC : chromophobe renal cell carcinoma; nccRCC : non-clear cell renal cell carcinoma; RCC : renal cell carcinoma; TCGA : The Cancer Genome Atlas; WGCNA: weighted gene

Protected

N/A

12
0
0
2020
Summary. Background. Signature: Pol J Radiol, 2017; 82: DOI: /PJR

ccRCC – clear cell renal cell carcinoma; chRCC – chromophobe renal cell carcinoma; pRCC – papillary renal cell carcinoma; sRCC – sarcomatoid renal cell carcinoma; cttRCC

Protected

N/A

8
0
0
2021
Comprehensive characterization of immune  and inflammation associated biomarkers based on multi omics integration in kidney renal clear cell carcinoma

KIRC: kidney renal clear cell carcinoma; RCC : renal cell carcinoma; ccRCC : clear cell renal cell carcinoma; TCGA : The Cancer Genome Atlas; GO: gene ontology; KEGG:

Protected

N/A

13
0
0
2020
Nodular Vascular Transformation of the Lymph Node Sinuses Mimicking Sarcomatoid Change in Renal Cell Carcinoma: A Potential Diagnostic Pitfall

vascular transformation of lymph node sinuses, sarcomatoid renal cell carcinoma, high-grade renal cell carcinoma, clear cell renal cell carcinoma, metastatic renal cell

Protected

N/A

6
0
0
2021
Cell death-related molecules and biomarkers for renal cell carcinoma targeted therapy

RCC : renal cell carcinoma; ccRCC : clear cell renal cell carcinoma; mRCC : metastatic renal cell carcinoma; pRCC : papillary renal cell carcinoma; MET: proto-oncogene MET;

Protected

N/A

15
0
0
2020
Neuroendocrin tumors, GIST, cancer of unknown primary. Renal neoplasms.

Acquired cystic disease-associated renal cell carcinoma Clear-cell papillary (tubulopapillary) renal cell carcinoma Hereditary leiomyomatosis-associated renal cell carcinoma Renal

Protected

N/A

44
0
0
2021
A distinctive, lowâ  grade oncocytic fumarate hydrataseâ  deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenaseâ  deficient renal cell carcinoma

Keywords: fumarate hydratase-deficient renal cell carcinoma, hereditary leiomyomatosis – renal cell carcinoma syndrome, oncocytic carcinoma, renal cell carcinoma,

Protected

N/A

11
0
0
2021
تازه های پرفشاری خون بر اساس گایدالین ISH2020 )به روش معرفی بیمار(

b) Lifestyle advice and immediate drug treatment c) Lifestyle advice for 3 months then drug treatment d)Immediate drug treatment.. His BP with ABPM= 150/95... What is your advice?

Protected

N/A

66
0
0
2021
Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma

BM: Bone metastases; ccRCC: Clear cell renal cell carcinoma; HIF1- α : Hypoxia-inducible factor 1-alpha; mRCC: Metastatic renal cell carcinoma; mTOR: Mammalian target of

Protected

N/A

5
0
0
2020
Histopathology and prognosis in renal cancer

Clear cell carcinoma 70-75% Papillary renal cell carcinoma 10-15% Chromophobe renal cell carcinoma 3-5% Oncocytoma 3-5% Others 1%. Clear cell

Protected

N/A

5
0
0
2021
A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma

RCC : renal cell carcinoma; ccRCC : clear cell renal cell carcinoma; UICC: Inter- national Union Against Cancer; AJCC: American Joint Committee on Cancer; lncRNAs: long noncoding

Protected

N/A

15
0
0
2020
Untargeted Contrast-Enhanced Ultrasound Versus Contrast-Enhanced Computed Tomography: A Differential Diagnostic Performance (DDP) Study for Kidney Lesions

KEYWORDS: Chromophobe Renal Cell Carcinoma; Contrast-Enhanced Computed Tomography; Contrast- Enhanced Ultrasound; Histopathology; Papillary Renal Cell Carcinoma; Renal Cell

Protected

N/A

8
0
0
2021
The prognostic effect of LINC00152 for cancer: a meta-analysisFei-Yu Quan

Colorectal cancer, gastric cancer, renal cell carcinoma, gallbladder cancer, lung cancer, hepatocellular carcinoma, and tongue squamous cell carcinoma were investigated in

Protected

N/A

7
0
0
2020

Upload more documents and download any material studies right away!